A prospective study from a tertiary care facility in North India on the function of vascular endothelial growth factor in tuberculous meningitis

Authors

  • P.SASIKALA Asst. Professor, DEPT OF Pharmacy Practice, NARAYANA PHARMACY COLLEGE, CHINTHA REDDY PALEM, NELLORE Author
  • B.SYED SALMAN Asso. Professor, DEPT OF PHARMACEUTICS, NARAYANA PHARMACY COLLEGE, CHINTHA REDDY PALEM, NELLORE Author
  • A. Ravi Kumar Asso. Professor, DEPT OF PHARMACOLOGY, NARAYANA PHARMACY COLLEGE, CHINTHA REDDY PALEM, NELLORE Author
  • Dr.k.Kishore kumar,professor Professor, DEPT OF Pharmaceutics, SWATHI COLLEGE OF PHARMACY, NELLORE Author
  • Dr.M.SREENIVASULU PRINCIPAL, NARAYANA PHARMACY COLLEGE, CHINTHA REDDY PALEM, NELLORE Author

Keywords:

Treatment for tuberculosis, utcome, B meningitis, VEFG

Abstract

The part that vascular endothelial-derived growth factor (VEFG) plays in the onset of tuberculousmeningitis (TBM) is still mostly unknown. We evaluated the role of VEFG in serum and CSF in TBMprospectively. PARTICIPATES AND METHODS: In this prospective study, researchers observedpatients at a hospital in northern India from January 2018 to June 2019. 82 consecutive drug-naiveTBM patients who were diagnosed using modified Ahuja's criteria were included in the study. 49healthy controls (n = 49) were used to compare the results. Serum and cerebral fluid levels of VEFGwere assessed in both patients and controls. 34 patients had their blood VEFG levels rechecked threemonths after completing antitubercular therapy. The levels of VEFG were determined using thehuman VEFG enzyme-linked immunosorbent assay kit.29.9 ± 13.1 years was the average age. Theseare the outcomes. The study group consisted of 33 men and 49 women (59.8% and 40.2%,respectively). Seventy-three patients (89%) had positive multiplex TB polymerase chain reactiontests, while thirteen patients (18%) had positive BACTEC MGIT960 tests. Patients with TBM did nothave greater levels of VEFG in their serum or cerebrospinal fluid than the control group. Serum VEFGlevel declines during follow-up were not linked to the final result in TBM. In conclusion, VEFG maynot have a major role in the emergence of TBM. Future studies with larger sample numbers could beable to clarify the VEFG status in TBM further.

References

ModiM,SharmaK,PrabhakarS,GoyalMK,TakkarA,SharmaN,etal.Clinicalandradiologicalpredictorsofoutcomeintubercularmeningitis: A prospective study of 209 patients. Clin NeurolNeurosurg2017;161:29‑34. P 0.6 P 0.4 TBM. Inanother study conducted on pediatric cell count and VEGF tomography, and MRI data of the present study in the pathogenesis of TBM. Although difference did not reach statistical significance. al.,[6]the present study did not find any correlation significant correlation between basal exudates due to be the unique genetic structure favor of the of TBM. role of VEFG in TBM.

SharmaS,GoyalMK,SharmaK,ModiM,SharmaM,KhandelwalN,etal.Cytokinesdoplayaroleinpathogenesisoftuberculousmeningitis:Aprospective studyfromatertiarycarecenterin India. J NeurolSci 2017;379:131‑6.

ThwaitesGE,TranTH.Tuberculousmeningitis:Manyquestions, toofewanswers.LancetNeurol2005;4:160‑70.

Rock RB, Olin M, Baker CA, Molitor TW, Peterson PK. Centralnervous system tuberculosis: Pathogenesis and clinical aspects.Clin Microbiol Rev 2008;21:243‑61.

ThwaitesGE,Macmullen‑PriceJ,TranTH,PhamPM,NguyenTD,SimmonsCP,etal.SerialMRItodeterminetheeffectofdexamethasoneonthecerebral pathologyoftuberculous meningitis: An observational study. Lancet Neurol2007;6:230‑6.

Misra UK, Kalita J, Singh AP, Prasad S. Vascular endothelialgrowthfactorintuberculousmeningitis.IntJNeurosci2013;123:128‑32.

KalitaJ,MisraUK,NairPP.Predictorsofstrokeanditssignificanceintheoutcomeoftuberculousmeningitis.JStroke Cerebrovasc Dis 2009;18:251‑8.

Misra UK, Kalita J, Srivastava R, Nair PP, Mishra MK, Basu A.Astudyofcytokinesintuberculousmeningitis:ClinicalandMRIcorrelation.NeurosciLett 2010;483:6‑10.

MatsuyamaW,HashiguchiT,UmeharaF,MatsuuraE,Kawabata M,Arimura K,etal.Expression ofvascularendothelial growth factor in tuberculous meningitis. J NeurolSci2001;186:75‑9.

van der Flier M, Hoppenreijs S, van Rensburg AJ, Ruyken M,Kolk AH, Springer P, et al. Vascular endothelial growth factorand blood‑brain barrier disruption in tuberculous meningitis.Pediatr Infect Dis J 2004;23:608‑13.

HusainN,AwasthiS,HarisM,GuptaRK,HusainM.Vascular endothelialgrowthfactorasamarkerofdiseaseactivityin neurotuberculosis.JInfect2008;56:114‑9.

JennettB,BondM.Assessmentofoutcomeafterseverebrain damage. Lancet 1975;1:480‑4.

RamakerC,MarinusJ,StiggelboutAM,VanHiltenBJ.SystematicevaluationofratingscalesforimpairmentanddisabilityinParkinson’s disease. Mov Disord 2002;17:867‑76.

Lamba PA, Bhalla JS, Mullick DN. Ocular manifestations oftubercular meningitis: A clinico‑biochemical study. J PediatrOphthalmolStrabismus 1986;23:123‑5.

Jain A, Goyal MK, Mittal BR, Sood A, Singh H, Vyas S, et al.18FDG‑PETissensitivetoolfordetectionofextracranialtuberculousfociincentralnervoussystemtuberculosis– PreliminaryobservationsfromatertiarycarecenterinNorthernIndia.JNeurolSci 2020;409:116585.

Downloads

Published

2026-03-11